Φορτώνει......

SoNar, a highly responsive NAD(+)/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents

The altered metabolism of tumor cells confers a selective advantage for survival and proliferation, and studies have shown that targeting such metabolic shifts may be a useful therapeutic strategy. We developed an intensely fluorescent, rapidly responsive, pH-resistant, genetically encoded sensor of...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	Cell Metab
Κύριοι συγγραφείς:	Zhao, Yuzheng, Hu, Qingxun, Cheng, Feixiong, Su, Ni, Wang, Aoxue, Zou, Yejun, Hu, Hanyang, Chen, Xianjun, Zhou, Hai-Meng, Huang, Xinzhi, Yang, Kai, Zhu, Qian, Wang, Xue, Yi, Jing, Zhu, Linyong, Qian, Xuhong, Chen, Lixin, Tang, Yun, Loscalzo, Joseph, Yang, Yi
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	2015
Θέματα:	Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4427571/ https://ncbi.nlm.nih.gov/pubmed/25955212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2015.04.009
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

SoNar, a highly responsive NAD(+)/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents

Παρόμοια τεκμήρια